Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A hyaluronic acid-docetaxel conjugate modified by dendrimers and its preparation method

A technology of docetaxel and hyaluronic acid, which is applied in the field of hyaluronic acid-docetaxel conjugates, can solve the problems of short residence time, high toxicity and side effects, and poor water solubility, so as to improve the therapeutic effect, prolong the circulation time, The effect of improving stability

Active Publication Date: 2022-03-08
SICHUAN UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although DTX shows an encouraging anti-tumor efficacy, it has the same limitations as other small molecule chemotherapy drugs, such as poor water solubility, lack of targeting, short residence time in the body, and high toxicity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A hyaluronic acid-docetaxel conjugate modified by dendrimers and its preparation method
  • A hyaluronic acid-docetaxel conjugate modified by dendrimers and its preparation method
  • A hyaluronic acid-docetaxel conjugate modified by dendrimers and its preparation method

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] A dendrimer-modified hyaluronic acid-docetaxel conjugate, the conjugate is hyaluronic acid loaded with docetaxel and a dendrimer, and the structure is as follows:

[0042]

[0043] Wherein, n is selected from 0, 1, 2, 3, 4, 5....

Embodiment 2

[0045] This embodiment is on the basis of embodiment 1:

[0046] The particle size of the conjugate is 118-126nm.

[0047] The molecular weight of the hyaluronic acid is 48000Da.

Embodiment 3

[0049]Synthesis of dendrimer-modified hyaluronic acid-docetaxel conjugates:

[0050]

[0051] Introduce aminoethanethiol on the hyaluronic acid as the carrier to obtain HA-SH for later use; couple the maleimide-modified GFLG with docetaxel to obtain the conjugate Mal-GFLG-DTX, and then pass the thiol -Ene click reaction to connect Mal-GFLG-DTX to HA-SH to obtain a conjugate intermediate; then connect the saccharified dendron-8Glu to the sulfhydryl group on hyaluronic acid through sulfhydryl exchange reaction to obtain the finished product .

[0052] The synthesis method of HA-SH and Dendron-8Glu refers to "Glycodendron / pyropheophorbide-a(Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy" (Carbohydrate Polymers, 2020, 247, 116749).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
particle diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention provides a dendrimer-modified hyaluronic acid-docetaxel conjugate, which is hyaluronic acid loaded with docetaxel and dendrimers, designed and synthesized with CD44 targeting The nanoparticle delivery carrier based on hyaluronic acid effectively improves the therapeutic effect of docetaxel on triple-negative breast cancer.

Description

technical field [0001] The invention relates to the technical field of biomedicine, in particular to a dendrimer-modified hyaluronic acid-docetaxel conjugate. Background technique [0002] Triple-negative breast cancer (TNBC) is a highly aggressive, highly metastatic systemic disease. Chemotherapy, as a long-term standard treatment for primary and metastatic tumors, is expected to achieve better therapeutic outcomes in TNBC treatment. Nanoparticles with active targeting function have become a research hotspot. By using the tumor microenvironment or the specificity of tumor cells, the specific delivery of drugs to tumor sites can be achieved, so as to achieve localized and efficient therapeutic effects and improve drug biosafety. sex. [0003] The transmembrane protein CD44 on the cell surface is closely related to the occurrence and development of tumors, and is highly expressed in many TNBC cells, which is closely related to the high invasion and high metastasis of TNBC. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08B37/08A61K31/337A61K47/61A61K47/64A61K47/69A61P35/00
CPCC08B37/0072A61K47/61A61K47/641A61K47/6939A61K31/337A61P35/00
Inventor 罗奎张孝琴
Owner SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com